Latest news with #ShantanuSengupta
The Hindu
3 days ago
- Health
- The Hindu
Health data at CFTRI, Mysuru, to be analysed using AI and machine learning
A five-day long extensive health checkup camp was organised at CSIR-CFTRI in Mysuru recently. The CSIR Health Cohort project is a multi-institutional, five-year long project covering across all CSIR laboratories. This project is being undertaken at the national level to develop clinically useful personalised risk predictions for various communicable and non-communicable diseases. Over 10,000 employees of CSIR, including retirees and their spouses, have been identified as subjects for this project. The project, CSIR Phenome India Health Cohort Project - Phase II Camp, started during 2022, and the first phase of the project was completed during February 2023 for CSIR-CFTRI. Those who have enrolled for this project have extensively undergone phlebotomy, including for CBC panel, Liver Function Test, and Kidney Function Test. The blood sample collected is being analysed for detailed biochemical markers as well as omics investigations, including genomics, proteomics, metabolomics, cytokines profile, and telomere length measurement. In addition, imaging and scanning was done through spirometry, ECG, body composition, liver scan, and oscillometry, etc. All the samples obtained from across the CSIR labs will be stored at CSIR Biobank at CSIR-IGIB, Delhi, under strict anonymity protocol, a press release, here, said. In this study, the large-scale cohort being implemented along all 40 CSIR labs spread across the country will serve as a national resource for identifying genetic, biochemical, and lifestyle risk factors. The data obtained will be analysed through AI and machine learning approaches for developing precision health care. The project is being coordinated by Shantanu Sengupta, Chief Scientist, CSIR-IGIB, Delhi. Like previous year, nearly 300 participants have undergone health check-up in the camp this year. The camp in Mysuru was inaugurated by Bhaskar Narayan, Director (Additional Charge), CSIR-CFTRI, in the presence of Prakash M. Halami and Muthukumar S.P., who are coordinating the project at the institutional level, the release added. The second phase of the testing camp had a specific health and nutritional questionnaire regarding food frequency, conducted by the Madras Diabetes Research Foundation. Due to consumption of highly processed food, there is a substantial increase in lifestyle disorders. Also, healthy ageing is one of the important agendas being noticed among senior citizens. Hence, more retirees participated in this phase. In this context, higher enrollment of subjects is being expected in phase III of the project, which will take place during mid-2026, said Mr. Halami.
Time of India
06-05-2025
- Health
- Time of India
Most Indian heart failure patients not getting lifesaving therapy, finds survey
Nagpur: A first-of-its-kind nationwide physician survey found that a majority of heart failure (HF) patients in India are not receiving guideline-directed medical therapy (GDMT) — a proven set of treatments that can significantly reduce hospitalisation and means using the best combination of medicines that have been proven to work for heart failure. These medicines help the heart pump better, reduce symptoms like breathlessness or swelling, and most importantly, help patients live longer and stay out of the across 27 states and one Union territory, the study gathered responses from over 5,000 doctors, making it one of the most comprehensive real-world assessments of heart failure care in India to date. The study, which recently appeared in the Journal of Cardiac Failure, was spearheaded by Dr Shantanu Sengupta, a senior cardiologist and researcher from Sengupta, the lead author, warned that the findings expose a serious gap in the standard of care for common Indian patients suffering from heart failure."This data tells us that many patients who should be receiving GDMT are simply not getting it — either due to lack of physician awareness, patient affordability, or systemic barriers," said Dr Sengupta, speaking to 54% of doctors said that only 1 in 4 of their patients were on proper GDMT, just 15% believed that more than three-quarters of their patients were receiving the recommended care. This means that thousands of patients may be left vulnerable to worsening heart failure due to under-treatment, despite clinical guidelines established by global and Indian cardiology typically includes a combination of medications, each targeting different aspects of heart failure pathology. When used in appropriate doses and combinations, GDMT has been shown to reduce mortality by nearly 60% in certain groups of heart failure patients."Patients and families must ask whether the following treatment plan includes GDMT. It's a matter of life and death," Dr Sengupta Common Patients Should Do* Know your EF (Ejection Fraction): Ask your doctor about your EF status* Demand clarity on medicines: Check if you're receiving beta-blockers, RAAS inhibitors* Monitor symptoms: Shortness of breath, leg swelling, and fatigue* Regular follow-up: GDMT needs regular dose adjustments and monitoringGDMT Gap in India* 5,012 doctors surveyed across 27 states and 1 UT* 53% physicians, 44% cardiologists, 2% endocrinologists* 54% said only 1 in 4 patients receive GDMT* 15% said more than 75% receive GDMT* 58% doctors in South zone say 25% patients on GDMT
